MARINA KONOPLEVA to Von Hippel-Lindau Tumor Suppressor Protein
This is a "connection" page, showing publications MARINA KONOPLEVA has written about Von Hippel-Lindau Tumor Suppressor Protein.
Connection Strength
0.206
-
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity. Nat Med. 2019 12; 25(12):1938-1947.
Score: 0.160
-
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity. Nat Commun. 2021 11 25; 12(1):6896.
Score: 0.046